Look Who it Was Random video

Archive: Newborn Screening and Post-Screening Analysis of Inborn Errors of Metabolism

1,830 views · Published 5 November 2018 · 1:01:09 · Indexed 7 October 2026

Channel: UW Video · 2018 · Education

Watch on YouTube

A subset of lysosomal storage diseases can now be treated, and early detection in newborns is key to a successful treatment outcome.  Described in this talk is a new technology based on tandem mass spectrometry for newborn screening of several lysosomal storage diseases.  Pilot studies of the technology shows that it is appropriate for population-based newborn screening.

After viewing this lecture, participants should be able to:
1. List three key advantages of using tandem mass spectrometry for newborn screening of inborn errors.
2. Describe the key advantage of using tandem mass spectrometry for post-screening diagnosis/prognosis studies.
3. Cite at least three reasons to include a new disease in a newborn screening panel.

Michael Gelb, PhD
Professor and Boris and Barbara L. Weinstein Endowed Chair in Chemistry
Departments of Chemistry and Biochemistry
University of Washington

10/31/18

http://depts.washington.edu/labweb/Education/ContEdu/
https://uw.edu/video
The University of Washington is committed to ensuring digital accessibility in our services, programs, and activities. If you encounter accessibility barriers using videos found on this channel, please contact UW Video at uwvideo [at] uw [dot] edu.

More from this channel